Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts

Federica Sotgia1, Francesco Del Galdo, Mathew C Casimiro

  • 1Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, 233 South 10 Street, Philadelphia, PA 19107, USA. federica.sotgia@jefferson.edu

Insights

Loss of caveolin-1 (Cav-1) in mammary fibroblasts causes functional retinoblastoma (RB) inactivation, mimicking cancer-associated fibroblasts. This Cav-1 loss promotes an invasive phenotype and predicts poor breast cancer outcomes.

Area of Science:

  • Cancer Biology
  • Cell Biology
  • Tumor Microenvironment

Background:

  • Human breast cancer-associated fibroblasts exhibit retinoblastoma (RB) tumor suppressor inactivation and reduced caveolin-1 (Cav-1) expression.
  • The direct causal link between Cav-1 loss and RB inactivation in mammary fibroblasts is not established.

Purpose of the Study:

  • To determine if Cav-1 deficiency is sufficient to cause functional RB inactivation in mammary fibroblasts.
  • To investigate the phenotypic characteristics of Cav-1 null mammary stromal fibroblasts (MSFs) and their impact on mammary epithelia.

Main Methods:

  • Phenotypic analysis of MSFs derived from Cav-1(-/-) mice.
  • Transcriptome analysis comparing Cav-1(-/-) MSFs with human cancer-associated fibroblasts.
  • Assessment of RB/E2F-regulated genes, RB hyperphosphorylation, and estrogen receptor co-activator gene expression.
  • Evaluation of paracrine effects using conditioned media from Cav-1(-/-) MSFs on wild-type mammary epithelia.
  • Proteomic analysis of conditioned media and assessment of MSF transdifferentiation.

Main Results:

  • Cav-1(-/-) MSFs share transcriptional profiles with human cancer-associated fibroblasts, showing RB/E2F gene up-regulation consistent with RB inactivation.
  • Cav-1(-/-) MSF gene signature predicts poor clinical outcomes in tamoxifen-treated breast cancer patients.
  • Conditioned media from Cav-1(-/-) MSFs induces epithelial-mesenchymal transition in wild-type mammary epithelia, indicating invasiveness.
  • Proteomic analysis revealed elevated proliferative/angiogenic factors in conditioned media, and Cav-1(-/-) MSFs exhibited endothelial-like transdifferentiation.

Conclusions:

  • Loss of Cav-1 in mammary fibroblasts is sufficient to induce functional RB inactivation and confer a cancer-associated fibroblast phenotype.
  • Cav-1 deficiency in the tumor microenvironment promotes an invasive epithelial phenotype and tumor angiogenesis.
  • These findings highlight the critical role of Cav-1 in maintaining fibroblast function and suppressing tumor progression.